|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Cytori Therapeutics Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Cytori Therapeutics (CYTX) develops, manufactures and sells medical technologies to enable the practice of regenerative medicine. The company provides a product pipeline for the treatment of cardiovascular disease, orthopedic damage, gastrointestinal disorders and pelvic health.
The company also focuses on reconstructive surgery in Europe, Asia-Pacific and the US and stem and regenerative cell banking (cell preservation) in Japan.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the five company over the last years.
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: ImmunoGen, Inc.
Company Financials: Allos Therapeutics, Inc.
Stem Cell Approaches in Neurology and Psychiatry 2010
Company Financials: Halozyme Therapeutics, Inc.
Company Financials: MDRNA, Inc.
Company Financials: Chelsea Therapeutics
Company Financials: BioMimetic Therapeutics, Inc.
Regenerative Medicine Markets
Company Financials: Eli Lilly and Company
Company Financials: Arqule, Inc.
|
|
|
|
